SLC5A2 and neoplasm: Conversely, preclinical studies suggest potential anti-tumor mechanisms operating both dependently and independently of SGLT2 inhibition, including impeding tumor glucose uptake, promoting apoptosis, altering oncogenic signaling, inducing cell cycle arrest, inhibiting angiogenesis, enhancing anti-tumor immunity, and attenuating chronic inflammation (42).